Published in Mol Immunol on February 01, 1990
Regulation of early complement components C3 and C4 in the synovium. Clin Diagn Lab Immunol (1996) 0.78
Metabolic alteration of the N-glycan structure of a protein from patients with a heterozygous protein deficiency. Biochim Biophys Acta (2004) 0.75
Classes and subclasses of rat immunoglobulins: interaction with the complement system and with staphylococcal protein A. Immunochemistry (1978) 2.06
Comparative study on antibodies to human and bacterial 60 kDa heat shock proteins in a large cohort of patients with coronary heart disease and healthy subjects. Eur J Clin Invest (2001) 1.66
HLA-B27-associated spondylarthritis in chronic brucellosis. Lancet (1978) 1.51
Interleukin 6 levels in synovial fluids of patients with different arthritides: correlation with local IgM rheumatoid factor and systemic acute phase protein production. J Rheumatol (1992) 1.25
The role of C3 in the immune response. Immunol Today (1991) 1.25
Histamine: an early messenger in inflammatory and immune reactions. Immunol Today (1992) 1.20
Epidemiology of the metabolic syndrome in Hungary. Public Health (2012) 1.19
A marked drop in the incidence of the null allele of the B gene of the fourth component of complement (C4B*Q0) in elderly subjects: C4B*Q0 as a probable negative selection factor for survival. Hum Genet (1991) 1.08
Association of elevated serum heat-shock protein 70 concentration with transient hypertension of pregnancy, preeclampsia and superimposed preeclampsia: a case-control study. J Hum Hypertens (2006) 1.07
Immunogenicity of antigen complexed with antibody. I. Role of different isotypes. Immunology (1982) 1.03
Functionally active C1 on the surface of human peripheral lymphocytes: its role in the complement-mediated inhibition of the Fc receptor of B lymphocytes. Clin Immunol Immunopathol (1976) 1.01
HIV and human complement: mechanisms of interaction and biological implication. Immunol Today (1993) 1.01
Possible mechanisms of the first step of the classical complement activation pathway: binding and activation of C1. Immunology (1978) 0.98
Antibodies against human heat-shock protein (hsp) 60 and mycobacterial hsp65 differ in their antigen specificity and complement-activating ability. Int Immunol (1999) 0.97
High levels of antibodies against Clq are associated with disease activity and nephritis but not with other organ manifestations in SLE patients. Clin Exp Rheumatol (2002) 0.97
The effect of immune complex composition on complement activation and complement dependent complex release. Immunochemistry (1978) 0.97
IgE class immune complexes in Felty's syndrome: characterisation of antibody activities in isolated complexes. Ann Rheum Dis (1984) 0.97
Ultrasonography in the diagnosis and monitoring of ascites in acute abdominal attacks of hereditary angioneurotic oedema. Eur J Gastroenterol Hepatol (2001) 0.97
Levamisole-induced neutropenia and agranulocytosis: association with HLA B27 leukocyte agglutinating and lymphocytotoxic antibodies. Int Arch Allergy Appl Immunol (1981) 0.96
Defensins purified from human granulocytes bind C1q and activate the classical complement pathway like the transmembrane glycoprotein gp41 of HIV-1. Mol Immunol (1997) 0.96
Classes and subclasses of rat antibodies: reaction with the antigen and interaction of the complex with the complement system. Immunology (1981) 0.96
The heterogeneity of Fc receptors on human peripheral mononuclear blood cells. Immunology (1979) 0.96
Interaction of C3 and C3b with immunoglobulin G. Mol Immunol (1983) 0.95
Effect of angiotensin II on macrophage functions. Immunology (1983) 0.94
Studies on the mechanism of complement-mediated inhibition of antibody binding to HIV gp41. Clin Exp Immunol (1993) 0.94
Serological abnormalities in juvenile chronic arthritis: a review of 46 cases. Ann Rheum Dis (1980) 0.93
Two parallel routes of the complement-mediated antibody-dependent enhancement of HIV-1 infection. AIDS (1997) 0.93
Effect of soluble immune complexes of Fc and C3 receptor-dependent phagocytosis by human monocytes. Immunology (1981) 0.92
Evaluation of different methods for detecting circulating immune complexes. An inter-laboratory study. J Immunol Methods (1980) 0.92
Isolation and characterization of Fc-receptors shed from human peripheral mononuclear cells. Immunology (1978) 0.91
Immunological alterations in anti-HTLV-III negative haemophiliacs and homosexual men in Hungary. Immunol Lett (1985) 0.91
Neutralizing and complement-dependent enhancing antibodies in different stages of HIV infection. AIDS (1991) 0.91
Eradication of Helicobacter pylori and improvement of hereditary angioneurotic oedema. Lancet (2001) 0.90
Activation of the complement system during infections due to gram-negative bacteria. Clin Immunol Immunopathol (1976) 0.90
Expression of alternatively spliced epidermal growth factor-like domains in aggrecans of different species. Evidence for a novel module. J Biol Chem (1993) 0.89
Association of polymorphisms and allelic combinations in the tumour necrosis factor-alpha-complement MHC region with coronary artery disease. J Med Genet (2002) 0.89
Strong correlation between the complement-mediated antibody-dependent enhancement of HIV-1 infection and plasma viral load. AIDS (1999) 0.89
Association between early onset and organ manifestations of systemic lupus erythematosus (SLE) and a down-regulating promoter polymorphism in the MBL2 gene. Clin Immunol (2007) 0.88
Angioedema due to acquired C1-esterase inhibitor deficiency in a patient with Helicobacter pylori infection. Z Gastroenterol (1999) 0.88
In vivo pulmonary toxicity of cellulose in rats. J Appl Toxicol (1997) 0.88
Smoking and a complement gene polymorphism interact in promoting cardiovascular disease morbidity and mortality. Clin Exp Immunol (2007) 0.87
Studies on the occurrence of circulating immune complexes in vascular diseases. Atherosclerosis (1978) 0.87
The efficacy of short-term danazol prophylaxis in hereditary angioedema patients undergoing maxillofacial and dental procedures. J Oral Maxillofac Surg (1999) 0.87
Subsets in psoriatic arthritis formed by cluster analysis. Clin Rheumatol (2001) 0.87
Low activity of the classical complement pathway predicts short survival of patients with chronic lymphocytic leukaemia. Clin Exp Immunol (1995) 0.86
A 60 kD heat-shock protein-like molecule interacts with the HIV transmembrane glycoprotein gp41. Mol Immunol (1999) 0.86
Interrelationship between the immunological and steroid hormone parameters in rheumatoid arthritis. Exp Clin Endocrinol (1986) 0.86
Plasma dehydroepiandrosterone, dehydroepiandrosterone sulphate and androsterone sulphate levels and their interaction with plasma proteins in rheumatoid arthritis. Exp Clin Endocrinol (1984) 0.86
Role of cellulose in wood dust-induced fibrosing alveo-bronchiolitis in rat. J Appl Toxicol (1995) 0.86
Sex hormones in hereditary angioneurotic oedema. Clin Endocrinol (Oxf) (2004) 0.86
Comparison of some blood parameters of captured and farmed red deer (Cervus elaphus) hinds. Acta Vet Hung (1996) 0.85
Epistatic effects of genes encoding immunoglobulin GM allotypes and interleukin-6 on the production of autoantibodies to 60- and 65-kDa heat-shock proteins. Genes Immun (2004) 0.85
Depressed classical complement pathway activities in chronic lymphocytic leukaemia. Clin Exp Immunol (1985) 0.85
Usefulness of densitometry in typing of human complement component C4. Immunogenetics (1989) 0.85
Dehydroepiandrosterone sulphate and bone mineral density. Osteoporos Int (1994) 0.84
Frequencies of certain complement protein alleles and serum levels of anti-heat-shock protein antibodies in cerebrovascular diseases. Stroke (2000) 0.84
Beta2-microglobulin-containing IgG complexes in sera and synovial fluids of rheumatoid arthritis and systemic lupus erythematosus patients. Scand J Immunol (1981) 0.84
BSA-anti-BSA immune complexes formed in the presence of human complement do not bind to autologous red blood cells. Immunology (1988) 0.84
High level of anticholesterol antibodies (ACHA) in HIV patients. Normalization of serum ACHA concentration after introduction of HAART. Immunobiology (2001) 0.84
Complement activation decreases the ability of HIV transmembrane envelope protein to bind to specific antibody. AIDS (1992) 0.84
The association of serum lipoprotein(a) levels, apolipoprotein(a) size and (TTTTA)(n) polymorphism with coronary heart disease. Clin Chim Acta (2001) 0.84
The severity of clinical symptoms in ragweed-allergic patients is related to the extent of ragweed-induced complement activation in their sera. Allergy (1997) 0.84
Levels of antibodies against C1q and 60 kDa family of heat shock proteins in the sera of patients with various autoimmune diseases. Immunol Lett (2001) 0.84
FN-C1q and C1 INH C1r-C1s complexes as indicators of complement activation in patients with chronic lymphocytic leukaemia. Immunol Lett (1989) 0.84
Evidences proving the intercalation hypothesis of the C-mediated complex release activity (CRA). Immunochemistry (1978) 0.84
Inhibition of the complement activation by an adrenal androgen, dehydroepiandrosterone. Complement (1984) 0.83
Angiooedema due to acquired deficiency of C1-esterase inhibitor associated with leucocytoclastic vasculitis. Acta Derm Venereol (2001) 0.83
Interaction of complement and specific antibodies with the external glycoprotein 120 of HIV-1. Immunology (1995) 0.83
Study of the interaction between monoclonal IgM proteins and the complement system. Immunochemistry (1976) 0.83
Regulation of Fc mu receptor-mediated functions of resident and provoked peritoneal macrophages. Immunobiology (1984) 0.83
C1 and C4 abnormalities in chronic lymphocytic leukaemia and their significance. Immunol Lett (1987) 0.83
Plasma bile acid levels and liver disease. Acta Med Acad Sci Hung (1981) 0.83
Study of the immune complex precipitation-inhibiting capacity of sera of patients with chronic lymphocytic leukaemia. Diagn Clin Immunol (1987) 0.83
Circulating ficolin-2 and ficolin-3 in normal pregnancy and pre-eclampsia. Clin Exp Immunol (2012) 0.83
Safety aspects of intravenous immunoglobulins. Immunol Invest (1988) 0.83
Studies on the mechanism of the complement-mediated inhibition of the Fc and C3 receptors of B lymphocytes. Clin Immunol Immunopathol (1977) 0.83
Free and complexed anti-lipoprotein antibodies in vascular diseases. Atherosclerosis (1983) 0.83
Stimulation of histamine receptors of human monocytoid and hepatoma-derived cell lines and mouse hepatocytes modulates the production of the complement components C3, C4, factor B, and C2. Scand J Immunol (1989) 0.82
Activation of the classical complement pathway by homogeneous anti-SIII antibody bound to bivalent or trivalent oligosaccharide antigens. Mol Immunol (1979) 0.82
Cytokine regulation of the acute-phase protein levels in multiple myeloma. Eur J Clin Invest (1998) 0.82
Danazol therapy for hereditary angio-oedema in children. Lancet (1999) 0.82
Antibodies against different epitopes of heat-shock protein 60 in children with type 1 diabetes mellitus. Immunol Lett (2002) 0.82